By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Hanmi Pharmaceutical, Co., Ltd 

45, Bandi-dong, Songpa-gu

Seoul    138-724  Korea
Phone: +82-31-371-5027 Fax: +82-31-371-5006




Company News
PlasmaTech Biopharmaceuticals' Partner Hanmi Pharma Receives Marketing Approval For MuGard In Korea 3/31/2015 7:04:16 AM
Eli Lilly (LLY), Hanmi Pharma Forge $690 Million Autoimmune Pact 3/19/2015 7:08:24 AM
Hanmi Pharmaceutical, Co., Ltd To Assign The Rights Of The Indian Territory To Kinex Pharmaceuticals As Part Of The Orascovery Program Strategic Plan 3/9/2015 10:48:36 AM
Spectrum Pharmaceuticals, Inc. (SPPI) In-Licenses Poziotinib, A Novel pan-HER Inhibitor With Clinical Activity In Several Solid Tumors, From Hanmi Pharmaceutical, Co., Ltd 3/4/2015 11:00:53 AM
Allegro Ophthalmics LLC And Hanmi Pharmaceutical, Co., Ltd Announce Strategic Investment And Collaboration To Develop And Market Luminate® In The Republic Of Korea And China 1/13/2015 10:41:33 AM
Hanmi Pharmaceutical, Co., Ltd And Collaborative Partner Kinex Pharmaceuticals Announce Preliminary Results From A Phase I Clinical Study (HM-OTE-103) With Oratecan® In Patients With Advanced Cancer 10/15/2014 7:56:26 AM
Spectrum Pharmaceuticals, Inc. (SPPI) Makes Decision To Advance SPI-2012, A Novel Long-Acting GCSF, To Phase 3 Due To Positive Phase 2 Results In Its Collaboration Program With Hanmi Pharmaceutical, Co., Ltd 9/9/2014 10:56:37 AM
Week In Review: Luye Acquires Hanmi Pharmaceutical, Co., Ltd's Oncology Drug For $20 Million 8/25/2014 9:07:02 AM
Luye In-Licenses China Rights To Cancer Drug From Korea's Hanmi Pharmaceutical, Co., Ltd 8/22/2014 12:25:35 PM
Hanmi Pharmaceutical, Co., Ltd And Collaborative Partner Kinex Pharmaceuticals Report Encouraging Results On Oraxol® For Patients With Advanced Gastric Cancer From A Phase I/II Clinical Study 6/30/2014 9:05:33 AM